Myriad Genetics Inc
MYGN- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000899923
No open-market purchases or sales by Myriad Genetics Inc insiders were filed in the last 90 days; 196 institutions reported holding it in 13F filings for Q2 2026, worth $507.8M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Myriad Genetics Inc as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 221
- +5 vs. Q3 2025
- Shares held
- 92.2M
- +4.67M (+5.3%) vs. Q3 2025
- Total value
- $567.1M
- −$65.8M (−10.4%) vs. Q3 2025
- New holders
- 31
- 85 more added
- Sold out
- 26
- 75 more reduced
5 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MYGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 196 | $507.8M |
| Q1 2026 | 204 | $519.2M |
| Q4 2025 | 221 | $567.1M |
| Q3 2025 | 221 | $639.8M |
| Q2 2025 | 221 | $480.5M |
| Q1 2025 | 228 | $832.9M |
| Q4 2024 | 221 | $1.27B |
| Q3 2024 | 246 | $2.48B |
| Q2 2024 | 223 | $2.25B |
| Q1 2024 | 186 | $2.00B |
| Q4 2023 | 194 | $1.72B |
| Q3 2023 | 186 | $1.33B |
| Q2 2023 | 188 | $1.88B |
| Q1 2023 | 190 | $1.91B |
| Q4 2022 | 196 | $1.17B |
| Q3 2022 | 191 | $1.55B |
| Q2 2022 | 199 | $1.46B |
| Q1 2022 | 205 | $1.99B |
| Q4 2021 | 197 | $2.16B |
| Q3 2021 | 213 | $2.56B |
| Q2 2021 | 201 | $2.31B |
| Q1 2021 | 197 | $2.25B |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Myriad Genetics Inc; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Connor, Clark & Lunn Investment Management Ltd. | 1,156,692 | $7.11M | 0.02% | −120,046−9.4% | Reduced |
| Assenagon Asset Management S.A. | 1,167,734 | $7.18M | 0.01% | −136,429−10.5% | Reduced |
| Nuveen, LLC | 1,190,566 | $7.32M | 0.00% | +465,670+64.2% | Added |
| Fisher Asset Management, LLC | 1,207,019 | $7.42M | 0.00% | −71,908−5.6% | Reduced |
| Vestal Point Capital, LP | 1,223,000 | $7.52M | 0.28% | +623,000+103.8% | Added |
| Point72 Asset Management, L.P. | 1,232,668 | $7.58M | 0.01% | +158,705+14.8% | Added |
| Dimensional Fund Advisors LP | 1,287,447 | $7.92M | 0.00% | −408,449−24.1% | Reduced |
| Federated Hermes, Inc. | 1,310,591 | $8.06M | 0.01% | +181,053+16.0% | Added |
| Charles Schwab Investment Management Inc | 1,753,711 | $10.8M | 0.00% | +74,811+4.5% | Added |
| AQR Capital Management LLC | 1,870,385 | $11.5M | 0.01% | +273,559+17.1% | Added |
| Goldman Sachs Group Inc | 2,160,282 | $13.3M | 0.00% | +8,503+0.4% | Added |
| Geode Capital Management, LLC | 2,231,292 | $13.7M | 0.00% | +6,123+0.3% | Added |
| Jacobs Levy Equity Management, Inc | 2,270,378 | $14.0M | 0.05% | −172,534−7.1% | Reduced |
| Morgan Stanley | 3,607,789 | $22.2M | 0.00% | −9,136−0.3% | Reduced |
| D. E. Shaw & Co., Inc. | 4,505,193 | $27.7M | 0.02% | −53,943−1.2% | Reduced |
| Glenview Capital Management, LLC | 4,587,407 | $28.2M | 0.60% | 00.0% | Unchanged |
| State Street Corp | 5,966,567 | $36.7M | 0.00% | +990,075+19.9% | Added |
| Millennium Management LLC | 6,700,158 | $41.2M | 0.03% | +1,951,831+41.1% | Added |
| Vanguard Group Inc | 8,225,371 | $50.6M | 0.00% | +342,856+4.3% | Added |
| BlackRock, Inc. | 15,303,850 | $94.1M | 0.00% | +424,423+2.9% | Added |
| DekaBank Deutsche Girozentrale | 35,272 | – | – | 00.0% | Unchanged |
| Anson Funds Management LP | 0 | $0 | 0.00% | −504,382−100.0% | Sold out |
| Janney Montgomery Scott LLC | 0 | $0 | 0.00% | −132,213−100.0% | Sold out |
| Weiss Asset Management LP | 0 | $0 | 0.00% | −130,343−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −129,521−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −53,129−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| ISAM Funds (UK) Ltd | 0 | $0 | 0.00% | −31,653−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −29,918−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −41,155−100.0% | Sold out |
| Brevan Howard Capital Management LP | 0 | $0 | 0.00% | −21,900−100.0% | Sold out |
| Quantessence Capital LLC | 0 | $0 | 0.00% | −19,113−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −18,407−100.0% | Sold out |
| Sender Co & Partners, Inc. | 0 | $0 | 0.00% | −17,270−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −15,400−100.0% | Sold out |
| Lazard Asset Management LLC | 0 | $0 | 0.00% | −14,670−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −12,764−100.0% | Sold out |
| Sanctuary Advisors, LLC | 0 | $0 | 0.00% | −12,720−100.0% | Sold out |
| OP Asset Management Ltd | 0 | $0 | 0.00% | −10,856−100.0% | Sold out |
| Plan A Wealth LLC | 0 | $0 | 0.00% | −10,625−100.0% | Sold out |
| Private Advisor Group, LLC | 0 | $0 | 0.00% | −10,297−100.0% | Sold out |
| FNY Investment Advisers, LLC | 0 | $0 | 0.00% | −2,930−100.0% | Sold out |
| GHP Investment Advisors, Inc. | 0 | $0 | 0.00% | −175−100.0% | Sold out |
| Kilter Group LLC | 0 | $0 | 0.00% | −72−100.0% | Sold out |
| Principal Securities, Inc. | 0 | $0 | 0.00% | −49−100.0% | Sold out |
| Huntington National Bank | 0 | $0 | 0.00% | −46−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −18−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | – | – | – | – | Not filed |
| AMH Equity Ltd | – | – | – | – | Not filed |
| Abich Financial Wealth Management LLC | – | – | – | – | Not filed |
| Point72 Asia (Singapore) Pte. Ltd. | – | – | – | – | Not filed |
| Point72 (DIFC) Ltd | – | – | – | – | Not filed |